They both lower the risk for heart-related complications, but differ in other approved uses and populations, side effects, dosage forms and costs
It occurs when blood supply to the optic nerve is reduced, leading to: Sudden, painless vision loss in one eye
Some of the key messages from the 2026 #ADA recommendations include: Treatment should be individualized according to cardiovascular risk, kidney disease, body weight, hypoglycemia risk and patient preferences
Liraglutide is expected to expand access for people managing type 2 diabetes, which affects more than 38 million Americans, according to federal health data
Prenatal exposure to GLP-1 receptor agonists and other second-line antidiabetics may not pose greater risk to infants than insulin For immediate release: December 11, 2023 Boston, MAInfants born to women with pre-gestational type 2 diabetes who take second-line non-insulin antidiabetic medications (ADMs) during pregnancy are at no higher risk of major congenital malformations (MCMs) than infants born to those who take insulin, according to a new study led by Harvard T.H